Angiotensin II induces superoxide anion production by mesangial cells

Kidney International

Volumn 54, Issue 3, 1998, Pages 775-784

  Jaimes, E A ^a   Galceran, J M ^a   Raij, L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Hyperplasia; Hypertrophy; Mesangium; NADPH oxidase; Nitric oxide; Superoxide

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; CALPHOSTIN C; GENISTEIN; HERBIMYCIN A; LOSARTAN; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; DISEASE COURSE; ENZYME ACTIVATION; GLOMERULUS CAPILLARY; HYPERPLASIA; HYPERTROPHY; KIDNEY BLOOD FLOW; KIDNEY INJURY; MESANGIUM CELL; MICROSCOPIC ANATOMY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

EID: 0031708389     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00068.x     Document Type: Article

References (54)

1. A.F. Michael W.F. Keane L. Raij R.L. Vernier S.M. Mauer The glomerular mesangium Kidney Int 17 1980 141 154
2. C. Sweeney P. Shultz L. Raij Interactions of the endothelium and mesangium in glomerular injury J Am Soc Nephrol 1 Suppl 1 1990 S13 S20
3. M.G. Seikaly B.S. Arant Jr F.D. Seney Jr Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat J Clin Invest 86 1990 1352 1357
4. P. Mene M.S. Simonson M.J. Dunn Physiology of the mesangial cell Physiol Rev 69 1989 1347 1424
5. L. Raij C. Baylis Glomerular actions of nitric oxide Kidney Int 48 1994 20 32
6. A. Huwiler S. Stabel D. Fabbro J. Pfeilschifter Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: Comparison of hypertrophic and hyperplastic agonists Biochem J 305 1995 777 784
7. M.W. Steffes R.W. Bilous D.E. Sutherland M. Mauer Cell and matrix components of the glomerular mesangium in type I diabetes Diabetes 41 1992 679 684
8. S. Kagami W.A. Border D.A. Miller N.A. Noble Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor β in rat glomerular mesangial cells J Clin Invest 93 1994 2431 2437
9. R. Tanaka K. Sugihara A. Tatematsu A. Fogo Internephron heterogeneity of growth factors and sclerosis-modulation of platelet derived growth factor by angiotensin II Kidney Int 47 1995 131 139
10. W.A. Border S. Okuda L.R. Languino M.B. Sporn E. Ruoslahti Suppresion of experimental glomerulonephritis by antiserum against transforming growth factor beta-1 Nature 346 1990 371 374
11. R.J. Johnson C.E. Alpers A. Yoshimura D. Lombardi P. Pritzl J. Floege S.M. Schwartz Renal injury from angiotensin II-mediated hypertension Hypertension 19 1992 464 474
12. M.E. Rosenberg L.J. Smith R. Correa Rotter T.H. Hostetter The paradox of the renin-angiotensin system in chronic renal disease Kidney Int 45 1994 403 410
13. S. Bjoerck H. Mulec S.A. Johnsen G. Norden M. Aurell Renal protective effect of enalapril in diabetic nephropathy Br Med J 304 1992 339 343
14. D.C. Cattran C. Greenwood S. Ritchie Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy Am J Kidney Dis 23 1994 247 254
15. E.J. Lewis L.G. Hunsicker R.P. Bain R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
16. S. Anderson H.G. Rennke B.M. Brenner Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1986 1993 2000
17. S. Anderson F.F. Jung J.R. Ingelfinger Renal renin-angiotensin system in diabetes: Functional, immunohistochemical and molecular biological correlations Am J Physiol 265 1993 F477 F486
18. P.W. Anderson Y.S. Do W.A. Hsueh Angiotensin II causes mesangial cell hypertrophy Hypertension 21 1993 29 35
19. H.H. Radeke A.R. Cross J.T. Hancock O.T. Jones M. Nakamura V. Kaever K. Resch Functional expression of NADPH oxidase components α and β subunits of cytochrome b-245, 45 kD flavoprotein by intrinsic mesangial cells J Biol Chem 266 1991 21026 21029
20. S.A. Jones J.T. Hancock O.T. Jones A. Neubauer N. Topley The expression of NADPH oxidase components in human glomerular mesangial cells: Detection of protein and mRNA for p47phox, and p22phox J Am Soc Nephrol 5 1995 1483 1491
21. K.K. Griendling C.A. Minieri J.D. Ollerenshaw R.W. Alexander Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ Res 74 1994 1141 1148
22. S. Rajagopalan S. Kurz T. Munzel M. Tarpey B.A. Freeman K.K. Griendling D.G. Harrison Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation J Clin Invest 97 1996 1916 1923
23. 2 J Pharmacol Exp Ther 279 1996 633 644
24. J.S. Beckman T.W. Beckman J. Chen P.A. Marshall B.A. Freeman Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide Proc Natl Acad Sci USA 87 1990 1620 1624
25. E.A. Jaimes K.A. Nath L. Raij Hydrogen peroxide downregulates IL-1 stimulated iNOS activity in mesangial cells: Implications for glomerulonephritis Am J Physiol 272 1997 F721 F728
26. P.J. Shultz M.A. Tayeh M.A. Marletta L. Raij Synthesis and action of nitric oxide in rat glomerular mesangial cells Am J Physiol 261 1991 F600 F606
27. Y. Ohara T.E. Peterson D.G. Harrison Hypercholesterolemia increases endothelial superoxide anion production J Clin Invest 91 1993 2546 2551
28. A. Mugge J.H. Elwell T.E. Peterson T.G. Hofmeyer D.D. Heistad D.G. Harrison Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vsacular relaxations in cholesterol-fed rabbits Circ Res 69 1991 1293 1300
29. B. Halliwell Reactive oxygen species in living systems: Source, biochemistry, and role in human disease Am J Med 91 Suppl 3C 1991 14S 22S
30. 2 for platelet-derived growth signal transduction Science 270 1995 296 299
31. Y.Y.C. Lo J.M.S. Wong T.F. Cruz Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases J Biol Chem 271 1996 15703 15707
32. S.D. Goldstone N.H. Hunt Redox regulation of the mitogen-activated protein kinase pathway Biochim Biophys Acta 1355 1997 353 360
33. F. Esposito F. Cuccovillo M. Vanoni F. Cimino C.W. Anderson E. Appella T. Russo Redox-mediated regulation of p21(waf1/cip1) expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway Eur J Biochem 245 1997 730 737
34. R.W. Alexander T.A. Brock M.A.J. Gimbrone S.E. Rittenhouse Angiotensin increases inositol triphosphate and calcium in vascular smooth muscle Hypertension 7 1985 447 451
35. T.A. Brock S.E. Rittenhouse C.W. Powers L.S. Ekstein M.A.J. Gimbrone R.W. Alexander Phorbol ester and 1-oleoyl-2acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells J Biol Chem 260 1985 14158 14162
36. J.W. Park C.R. Hoyal J.E. Benna B.M. Babior Kinase-dependent activation of the leukocyte NADPH oxidase in a cell free system J Biol Chem 272 1997 11035 11043
37. P. Dieter Relationship between intracellular pH changes, activation of protein kinase and NADPH oxidase in macrophages FEBS Lett 298 1992 17 20
38. R.M. Touyz E.L. Schiffrin Angiotensin II regulates vascular smooth cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways Hypertension 30 part 1 1997 222 229
39. K.K. Griendling S.E. Rittenhouse T.A. Brock L.S. Ekstein M.A.J. Gimbrone R.W. Alexander Sustained diacylglycerol formation from insoitol phospholipids in angiotensin II-stimualted vascular smooth muscle cells J Biol Chem 261 1986 5901 5906
40. B.C. Berk M.A. Corson Angiotensin II signal transduction in vascular smooth muscle role of tyrosine kinases Circ Res 80 1997 607 616
41. 2+ mobilization and protein kinase C activation J Biol Chem 264 1989 526 530
42. J.L. Duff B.C. Berk M.A. Corson Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells Biochem Biophys Res Commun 188 1992 257 264
43. 2+-dependent signaling Circ Res 76 1995 1 15
44. R. Seger E.G. Krebs The MAPK signaling cascade FASEB J 9 1995 726 735
45. M.J. Servant E. Giasson S. Meloche Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells J Biol Chem 271 1996 16047 16052
46. S. Cowley H. Paterson P. Kemp C.J. Marshall Activation of MAP kinase kinase is neccesary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells Cell 77 1994 841 852
47. J. Ruef Z.Y. Hu L.Y. Yin Y. Wu S.R. Hanson A.B. Kelly L.A. Harker G.N. Rao M.S. Runge C. Patterson Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis Circ Res 81 1997 24 33
48. P. Delafontaine L. Ku Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells Cardiovasc Res 33 1997 216 222
49. L.M. Landino B.C. Crews M.D. Timmons J.D. Morrow L.J. Marnett Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin synthesis Proc Natl Acad Sci USA 93 1996 15069 15074
50. R. Morishita G.H. Gibbons K.E. Ellison W. Lee L. Zhang H. Yu Y. Kaneda T. Ogihara V.J. Dzau Evidence for direct local effect of angiotensin in vascular hypertrophy in vivo gene transfer of angiotensin converting enzyme J Clin Invest 94 1994 978 984
51. M. Takemoto K. Egashira M. Usui K. Numaguchi H. Tomita H. Tsutsui H. Shimokawa K. Sueishi A. Takeshita Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long term blockade of nitric oxide synthesis in rats J Clin Invest 99 1997 278 287
52. S. Ito C.S. Johnson O.A. Carretero Modulation of angiotensin-II induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole J Clin Invest 87 1991 1656 1663
53. M.J. Pollman T. Yamada M. Horiuchi G.H. Gibbons Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II Circ Res 79 1996 748 756
54. A. Wolny J.-P. Clozel J. Rein P. Mory P. Vogt M. Turino W. Kiowski W. Fischili Functional and biochemical analysis of angiotensin II-forming pathways in the human heart Circ Res 80 1997 219 227